Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
60 studies found for:    "Optic neuritis"
Show Display Options
RSS Create an RSS feed from your search for:
"Optic neuritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Ampyra for Optic Neuritis in MS
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Dalfampridine/Placebo;   Drug: Placebo/Dalfampridine
2 Recruiting Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial
Condition: Optic Neuritis
Interventions: Drug: Erythropoietin alfa;   Drug: Placebo
3 Recruiting Amiloride Clinical Trial In Optic Neuritis
Conditions: Optic Neuritis;   Multiple Sclerosis
Interventions: Drug: Amiloride;   Drug: Placebo
4 Unknown  Lipoic Acid as a Treatment for Acute Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Lipoic Acid
5 Recruiting Neuroprotection With Phenytoin in Optic Neuritis
Conditions: Optic Neuritis;   Multiple Sclerosis
Interventions: Drug: Phenytoin;   Drug: Placebo
6 Unknown  Simvastatin Treatment of Patients With Acute Optic Neuritis
Conditions: Optic Neuritis;   Multiple Sclerosis
Interventions: Drug: simvastatin;   Drug: placebo
7 Recruiting Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: ACTHAR
8 Completed Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Erythropoietin
9 Completed 215ON201 BIIB033 In Acute Optic Neuritis (AON)
Condition: Acute Optic Neuritis
Interventions: Biological: BIIB033 (anti-LINGO-1 mAb);   Drug: Placebo
10 Completed Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)
Condition: Acute Demylelinating Optic Neuritis
Interventions: Drug: Fingolimod 0.5mg/daily;   Drug: Placebo
11 Unknown  Optic Neuritis Recovery After Oral or IV Corticosteroids
Condition: Optic Neuritis
Intervention: Drug: corticosteroids
12 Completed Visual Reconstitution Therapy After Optic Neuritis
Conditions: Optic Neuritis;   Multiple Sclerosis
Interventions: Other: Visual Reconstitutions Therapy;   Other: Saccadic Eye Movement Training
13 Completed Interest of Dynamic Measures of the Pupil in Optic Neuritis
Condition: Optic Neuritis
Intervention: Other: measure of pupil diameter
14 Completed TLR-9 Antagonism in Steroid Resistant Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Mycobacterium w.(Mw)-freeze dried extract 0.5ml
15 Terminated Neuroprotection and Repair in Optic Neuritis
Conditions: Multiple Sclerosis;   Optic Neuritis
Intervention: Drug: Minocycline
16 Terminated Atacicept in Optic Neuritis, Phase II
Condition: Optic Neuritis
Interventions: Drug: Atacicept;   Drug: Placebo
17 Unknown  Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography
Condition: Optic Neuritis
Interventions: Drug: Vitamin D;   Drug: Vitamin D withheld
18 Completed
Has Results
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Condition: Optic Neuritis
Interventions: Drug: Glatiramer Acetate;   Drug: placebo
19 Unknown  Optic Neuritis Treatment Trial (ONTT)
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone
20 Unknown  Longitudinal Optic Neuritis Study (LONS)
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years